Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Boehringer Ingelheim
McKesson
Colorcon

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Optopics Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for OPTOPICS, and what generic and branded alternatives to OPTOPICS drugs are available?

OPTOPICS has three approved drugs.



Summary for Optopics
US Patents:0
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for Optopics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Optopics OPTOMYCIN chloramphenicol SOLUTION/DROPS;OPHTHALMIC 062171-001 Mar 31, 1982 DISCN No No   Start Trial   Start Trial
Optopics SULFACEL-15 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080024-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Optopics PARACAINE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 087681-001 Aug 5, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Moodys
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.